(Q34133411)

31 July 2017

1 reference

title

Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men. (English)

1 reference

31 July 2017

Cooney KA

1

1 reference

31 July 2017

Strawderman MS

2

1 reference

31 July 2017

Wojno KJ

3

1 reference

31 July 2017

Doerr KM

4

1 reference

31 July 2017

Taylor A

5

1 reference

31 July 2017

Alcser KH

6

1 reference

31 July 2017

Heeringa SG

7

1 reference

31 July 2017

Taylor JM

8

1 reference

31 July 2017

Wei JT

9

1 reference

31 July 2017

Montie JE

10

1 reference

31 July 2017

Schottenfeld D

11

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

57

1 reference

31 July 2017

91-96

1 reference

31 July 2017

1

1 reference

Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900873-6

7 January 2021

The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900873-6

7 January 2021

Prostate-specific antigen in black men

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900873-6

7 January 2021

Comparability of serum prostate-specific antigen measurement between the hybritech Tandem-R and Abbott AxSYM assays

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900873-6

7 January 2021

Prostate-specific antigen as predictor of prostate cancer in black men and white men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900873-6

7 January 2021

Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900873-6

7 January 2021

Age-specific reference ranges for serum prostate-specific antigen in black men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900873-6

7 January 2021

Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900873-6

7 January 2021

Reference ranges for serum prostate-specific antigen in black and white men without cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900873-6

7 January 2021

Alcohol and prostate cancer in the NHANES I epidemiologic follow-up study. First National Health and Nutrition Examination Survey of the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900873-6

7 January 2021

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900873-6

7 January 2021

Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900873-6

7 January 2021

Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900873-6

7 January 2021

Cancer incidence in the rural community of Tecumseh, Michigan: a pattern of increased lymphopoietic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900873-6

7 January 2021

10.1016/S0090-4295(00)00873-6

Identifiers

DOI

1 reference

31 July 2017

1 reference